Diagnostic anti-Human Fatty Acid Binding Protein (HFABP) antibodies (anti-Human Fatty Acid Binding Protein, anti-HFABP) and diagnostic hapten-carrier conjugates BSA-Human Fatty Acid Binding Protein (HFABP), OVA-Human Fatty Acid Binding Protein (HFABP), KLH-Human Fatty Acid Binding Protein (HFABP) antigens for Cardiovascular disease HFABP detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Genemedi produces core diagnostic ingredients for test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome. GeneMedi offers paired anti-Human Fatty Acid Binding Protein (HFABP) antibodies (monoclonal antibody, mab) and Human Fatty Acid Binding Protein (HFABP antigens (Carrier-coupled antigen, immunogen, hapten-carrier conjugates, BSA-conjugated, OVA-conjugated, KLH-conjugated) for Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) rapid test kit of Human Fatty Acid Binding Protein (HFABP) testing in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. The carrier-coupled antigens of small molecules can act as immunogens.The fatty acid binding proteins (FABPs) are a family of transport proteins for fatty acids and other lipophilic substances such as eicosanoids and retinoids. These proteins are thought to facilitate the transfer of fatty acids between extracellular and intracellular membranes. FABP4 has been associated with several components of metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation, and thus, it has been proposed as a cardiometabolic predictor for cardiovascular disease.